News

NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine ...
Sexually transmitted infections (STIs) result in millions of cases and cost over $16 billion annually in the U.S. High asymptomatic rates and stigma hinder timely diagnosis and elimination efforts.
Mar. 19, 2025 — A study has found that a single dose of the Imvanex vaccine provides protection against Mpox with 84% effectiveness ... 2025 — Infection with Zika virus in pregnancy can ...
Mpox is caused by a virus from the same family as smallpox, manifesting in a high fever and skin lesions, called vesicles. First identified in the Democratic Republic of Congo in 1970, the disease ...
The UK MHRA has granted marketing authorisation to Bavarian Nordic's Vimkunya vaccine for preventing the chikungunya virus.
A panel of public health experts will convene in May 2025 to evaluate whether mpox should continue to be classified as a ...
Into the Shadows on MSN5d
Mpox: The Next Pandemic?
Mpox. Once a rare virus, it’s now spreading globally. Learn about its history, symptoms, and why we can't afford to ignore this emerging crisis.
ACAM200 can be used for people at high risk of mpox, according to the company, with the news causing shares in Emergent to spike more than 27% in pre-market trading. The virus that causes mpox ...
TPOXX is approved for smallpox, but has been used off-label to treat mpox (formerly known as monkeypox), which is in the same virus family, in many countries. The antiviral was also cleared in the ...
Researchers at Uppsala University have now developed an AI model that can determine with 90 per cent certainty which variant the patient has. The model increases the chances of starting the right ...
In addition to its role in combating plant pathogens, it serves as a model virus commonly used in research to study how bacteriophages interact with their host bacteria. Using cryo-electron ...
The influenza A virus redirects the RNA interference protein AGO2 into the cell nucleus, where it suppresses type I interferon genes, weakening immune signaling.